Deutsche Bank Ag\ Evogene Ltd. Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$1.98 - $3.01 $15,840 - $24,080	-8,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.6 - $3.14 $20,020 - $24,178	7,700 Added 2566.67%	8,000 $24,000
Q2 2018 Aug 14, 2018	SELL	$2.84 - $3.29 $17,272 - $20,009	-6,082 Reduced 95.3%	300 $0
Q1 2018 May 15, 2018	SELL	$3.15 - $4.16 $5,411 - $7,146	-1,718 Reduced 21.21%	6,382 $20,000
Q4 2017 Feb 14, 2018	BUY	$3.07 - $4.68 $24,560 - $37,440	8,000 Added 8000.0%	8,100 $24,000
Q3 2017 Nov 14, 2017	BUY	$4.24 - $5.06 $424 - $505	100	100 $0

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $68M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.